Figure S3 from IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance

Authors :: Giusy Di Conza
Lars van der Veen
Francesco Bertoni
Denis Migliorini
Mathias Wenes
Dominique Perrin
Michael Lahn
Karolina Niewola-Staszkowska
Andrea Rinaldi
Sara Napoli
Tyzoon Nomanbhoy
Pritom Shah
Amy Fraser
Filippo Spriano
Luciano Cascione
Elisa Civanelli
Chiara Tarantelli
Zoë Johnson
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Correlation analysis of PI3Kd levels and the response to IOA-244 and Idelalisib

Tools